Table 3.
Clinical and dosemiteric factors in patients with and without hypothyroidism
| |
Normal |
Hypothyroidism |
P
|
|---|---|---|---|
| (n = 48) | (n = 52) | ||
| Median Age (year) |
53 |
48 |
0.23 |
| Comorbidity |
9 |
8 |
0.30 |
| Surgery |
16 |
14 |
0.26 |
| Chemotherapy |
32 |
29 |
0.22 |
| Gender |
|
|
0.12 |
| Female |
46% |
54% |
|
| Male |
60% |
40% |
|
| |
Median (range) |
|
|
| Thyroid volume |
31.59 (5.7–99) |
14.25 (0.6–69.6) |
0.01 |
| Dmin (≥40.1 Gy) |
48.1 (0–61.0) |
52.1 (0.6–59.7) |
0.42 |
| Dmax (≥57.6 Gy) |
50 (19.9–75.3) |
47.9 (19.4–71.0) |
0.49 |
| Dmean (≥47.3 Gy) |
44.2 (5.7–67.3) |
56.2 (3.8–66.5) |
0.03 |
| V10 (≥100%) |
75.0 (13–100) |
89.1 (9–100) |
0.06 |
| V20 (≥100%) |
67.5 (7–100) |
82.6 (0–100) |
0.06 |
| V30 (≥100%) |
59.6 (0–100) |
78.3 (0–100) |
0.03 |
| V40 (≥94%) |
45.9 (0–100) |
53.6 (0–100) |
0.36 |
| V50 (≥44%) | 54.8 (0–100) | 45.2 (0–100) | 0.06 |